HF
EDSA icon

HRT Financial’s Edesa Biotech EDSA Stock Holding History

HRT Financial’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$256K Buy
+31,531
New +$284K ﹤0.01% 3217

Other funds holding EDSA

VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

HRT Financial's EDSA Position: Q2 2026 in Review

HRT Financial opened a new position in Edesa Biotech (EDSA) in Q2 2026: 31,531 shares worth $256K. The stake represents ﹤0.01% of the portfolio and ranks #3217 among its holdings.

30 funds tracked by Wall St. Rank hold EDSA as of Q2 2026.

  • HRT Financial held 31,531 shares of Edesa Biotech worth $256K as of Q2 2026.
  • Edesa Biotech was a new HRT Financial position in Q2 2026.
  • Edesa Biotech made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3217 holding.
  • 30 funds tracked by Wall St. Rank held Edesa Biotech as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.